Hematology Advisor

The use of complement inhibitors appears to reduce the risk of TEs among patients diagnosed with #paroxysmalNocturnalHemoglobinuria. Published in American Society of Hematology journal Blood. #PHN

Many patients with #cancer and other medical conditions want to discuss treatment costs with their physicians, given that associated costs often lead to #financialToxicity. But less than one-third of patients report having such discussions. Published in The Oncologist Journal and Oncology Nurse Advisor.

Short-term systemic adverse effects after #COVID19 mRNA vaccination may be indicative of increased long-lasting nAb responses. Published in Infectious Disease Advisor. #COVID19Vaccine

Patients with chronic #lymphocyticLeukemia or #nonHodgkinLymphoma who underwent IgG testing and treated if found to have hypogammaglobulinemia demonstrated lower rates of infections and antimicrobial use. Published in American Society of Hematology journal Blood Advances. #CLL

An increase in oxidative metabolism triggers intracellular fumarate accumulation in mesenchymal stromal cells in #myelofibrosis and drives cellular senescence and the onset of fibrosis. Presented at the European Hematology Association (EHA) 2024 hybrid congress. From Rare Disease Advisor #EHA2024.

The implementation of MRD assessment based on next generation sequencing could improve prognostic accuracy in acute #lymphoblasticLeukemia. From Rare Disease Advisor. #leusm

Use of an AI-based algorithm for radiologic response assessment in #cancer imaging showed performance considered similar to that observed through the assessments of medical experts in a study reported in the American Society of Clinical Oncology (ASCO) Journal of Clinical Oncology.

Patients with advanced-stage, classical #HodgkinLymphoma may benefit from receiving a novel BrECADD regimen guided by PET after 2 cycles. Published in The Lancet.

The use of complement inhibitors appears to reduce the risk of TEs among patients diagnosed with #paroxysmalNocturnalHemoglobinuria. Published in American Society of Hematology journal Blood. #PNH

Adding daratumumab to treatment with VTd significantly improves survival outcomes in patients with newly diagnosed #multipleMyeloma. Published in The Lancet Oncology and Cancer Therapy Advisor.